Task: Answer the multiple-choice question.
Query: Which drug exhibits a 1.265% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. Cc1ccc(S(=O)(=O)CCC(=O)OCC(=O)c2c(C)[nH]c3ccccc23)cc1
b. O=C(Cn1cnc2c(NC(=O)OCc3ccccc3)ncnc21)NCCN1CCOCC1
Answer: b. O=C(Cn1cnc2c(NC(=O)OCc3ccccc3)ncnc21)NCCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Cn1cnc2c(NC(=O)OCc3ccccc3)ncnc21)NCCN1CCOCC1
O=C(Cn1cnc2c(NC(=O)OCc3ccccc3)ncnc21)NCCN1CCOCC1
benzyl N-[9-[2-(2-morpholin-4-ylethylamino)-2-oxoethyl]purin-6-yl]carbamate